185 related articles for article (PubMed ID: 36232657)
1. An Analysis of the Effects of In Vitro Photodynamic Therapy on Prostate Cancer Tissue by Histopathological Examination and Magnetic Resonance Imaging.
Aebisher D; Osuchowski M; Bartusik-Aebisher D; Krupka-Olek M; Dynarowicz K; Kawczyk-Krupka A
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232657
[TBL] [Abstract][Full Text] [Related]
2. Histopathological Analysis of the Effect of Photodynamic Action on Post-Chemotherapy Excised Breast Cancer Tissue.
Ostańska E; Barnaś E; Bartusik-Aebisher D; Dynarowicz K; Szpunar M; Skręt-Magierło J; Aebisher D
Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743961
[No Abstract] [Full Text] [Related]
3. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
4. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives.
Fidanzi-Dugas C; Liagre B; Chemin G; Perraud A; Carrion C; Couquet CY; Granet R; Sol V; Léger DY
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1676-1690. PubMed ID: 28188858
[TBL] [Abstract][Full Text] [Related]
6. Monitoring photodynamic oxygen consumption by endogenous oxygen contrast MRI.
Ożóg Ł; Domka W; Truszkiewicz A; Tarbarkiewicz J; Aebisher D
Photodiagnosis Photodyn Ther; 2019 Mar; 25():492-498. PubMed ID: 30738846
[TBL] [Abstract][Full Text] [Related]
7. Rose Bengal and Future Directions in Larynx Tumor Photodynamic Therapy.
Bartusik-Aebisher D; Ożóg Ł; Domka W; Aebisher D
Photochem Photobiol; 2021 Nov; 97(6):1445-1452. PubMed ID: 34287926
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of 5-ALA mediated photodynamic therapy on hypoxic prostate cancer: a preclinical study on the Dunning R3327-AT2 rat tumor model.
Bozzini G; Colin P; Betrouni N; Maurage CA; Leroy X; Simonin S; Martin-Schmitt C; Villers A; Mordon S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):296-303. PubMed ID: 23993856
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic and Sonodynamic Therapy with Protoporphyrin IX: In Vitro and In Vivo Studies.
Ponce Ayala ET; Alves Dias de Sousa F; Vollet-Filho JD; Rodrigues Garcia M; de Boni L; Salvador Bagnato V; Pratavieira S
Ultrasound Med Biol; 2021 Apr; 47(4):1032-1044. PubMed ID: 33446374
[TBL] [Abstract][Full Text] [Related]
10. Predictors of therapeutic efficacy of 5-aminolevulinic acid-based photodynamic therapy in human prostate cancer.
Yamamoto S; Fukuhara H; Seki H; Kawada C; Nakayama T; Karashima T; Ogura SI; Inoue K
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102452. PubMed ID: 34303032
[TBL] [Abstract][Full Text] [Related]
11. A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer.
Yamauchi M; Honda N; Hazama H; Tachikawa S; Nakamura H; Kaneda Y; Awazu K
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):48-54. PubMed ID: 24629697
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic Treatment of Human Breast and Prostate Cancer Cells Using Rose Bengal-Encapsulated Nanoparticles.
Uddin MMN; Bekmukhametova A; Antony A; Barman SK; Houang J; Wu MJ; Hook J; George L; Wuhrer R; Mawad D; Ta D; Lauto A
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836744
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic Therapy-Adjunctive Therapy in the Treatment of Prostate Cancer.
Osuchowski M; Aebisher D; Bartusik-Aebisher D; Krupka-Olek M; Dynarowicz K; Przygoda M; Kawczyk-Krupka A
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626269
[TBL] [Abstract][Full Text] [Related]
14. Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells.
Ortel B; Sharlin D; O'Donnell D; Sinha AK; Maytin EV; Hasan T
Br J Cancer; 2002 Nov; 87(11):1321-7. PubMed ID: 12439724
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
16. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M
BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764
[TBL] [Abstract][Full Text] [Related]
17. Photosensitiser functionalised luminescent upconverting nanoparticles for efficient photodynamic therapy of breast cancer cells.
Buchner M; García Calavia P; Muhr V; Kröninger A; Baeumner AJ; Hirsch T; Russell DA; Marín MJ
Photochem Photobiol Sci; 2019 Jan; 18(1):98-109. PubMed ID: 30328457
[TBL] [Abstract][Full Text] [Related]
18. Interstitial photodynamic therapy in the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX.
Chang SC; Buonaccorsi GA; MacRobert AJ; Bown SG
Prostate; 1997 Jul; 32(2):89-98. PubMed ID: 9215396
[TBL] [Abstract][Full Text] [Related]
19. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
20. Rose Bengal incorporated to α-cyclodextrin microparticles for photodynamic therapy against the cariogenic microorganism Streptococcus mutans.
Alexandrino FJR; Bezerra EM; Da Costa RF; Cavalcante LRL; Sales FAM; Francisco TS; Rodrigues LKA; de Brito DHA; Ricardo NMPS; Costa SN; de Lima-Neto P; Barroso-Neto IL; Caetano EWS; Freire VN
Photodiagnosis Photodyn Ther; 2019 Mar; 25():111-118. PubMed ID: 30468898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
